News

A pediatrician's guide to the new baby food safety regulations from Tanya Altmann, MD, FAAP.

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing the biologic.

The indication is supported by trial data showing three-fourths of successfully treated patients maintained clear skin through 1 year of a lebrikizumab regimen.

A new study suggests an early AI-powered algorithm could help accurately identify common movements exhibited by children with autism spectrum disorder.

The CDC committee has set new recommendations based on children's age, vaccination status, and overall immunity health, for the 2024 - 2025 period.

Findings from a newly-published study revealed that newborn metabolic profiles may identify infants at an increased risk for SIDS shortly after birth.

Linda DiMeglio, MD, MPH, joined us to discuss the “Consensus Guidance for Monitoring Persons with Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes."

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Can you diagnose this adolescent with an 11-day history of diffuse targetoid and bullous lesions on his extremities and trunk?

Alan Percy, MD, discusses where the general provider comes in when treating Rett syndrome and prescribing trofinetide (Daybue).

"The quest for a cure for colic continues," noted Jon Matthew Farber, MD.

Investigators concluded that findings suggest the need for improved public health messaging regarding fish intake guidelines for pregnant persons.

In this last episode, our panel discusses this patient population and the challenges around keeping them in the continuum of care.

Availability for the type 1 allergic reactions treatment approved by the FDA in August is expected later this month.

Alan Percy, MD, discussed what the FDA approval of trofinetide (Daybue) has meant to patients with Rett syndrome aged 2 years and older.

As providers, it’s imperative to reward engagement and build on the successes of the professionals who invest their time and talent into the mission of our organization.

Screen time before bed did not impair sleep in children, but in-bed use demonstrated delayed sleep onset and reduced total sleep time.

"This is another example of how people trying to find a useful therapeutic role for magnesium usually come up short," stated Jon Matthew Farber, MD.

Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the August 2024 issue of Contemporary Pediatrics.

Sleep deprivation and impairment can significantly hinder childhood development, affecting cognition, school performance, mood, behavior, physical health, and overall quality of life.

"Bottom line: It should be safe (there is a potential for freeze burns if misapplied), so patients are welcome to try it," said Jon Matthew Farber, MD.

Following the final ruling, requirements will be implemented beginning September 30, 2024.

The investigational MEK inhibitor has been assigned a Prescription Drug User Fee Act (PDUFA) date of February 28, 2025.

In this episode, clinicians discuss challenges associated with these topics and offer some insights on them.

Efficacy of roflumilast cream 0.05% improved over time among children aged 2 to 5 years with mild to moderate atopic dermatitis.

IIV3s, RIV3, and LAIV3 influenza vaccines are expected to be available.

The report links high fluoride exposure to lower IQ in children, though the American Fluoridation Society noted the high levels are more than double what is used for water fluoridation in North America.